Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.79%
#4 Black Phoenix Black Phoenix +334.12%
#5 aPriori aPriori +109.83%
#6 Bedrock Bedrock +68.47%
#7 COTI COTI +40.17%
#8 Cysic Cysic +39.09%
#9 Prom Prom +36.56%
#10 Playnance Playnance +34.54%
Coin of the day
Wrapped One Wrapped One
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
GlobeImmune, Inc. GlobeImmune, Inc.

GlobeImmune, Inc.

GBIM
Rang in Aktien #42634
GlobeImmune, Inc., a biopharmaceutical firm based in Louisville, Colorado, and... GlobeImmune, Inc., a biopharmaceutical firm based in Louisville, Colorado, and founded in 1995 (originally Ceres Pharmaceuticals, Inc. until its rebranding in May 2001), specializes in creating therapeutic products for both cancer and infectious diseases. Central to its development efforts is its unique Tarmogen platform. The company's pipeline includes several key candidates: For infectious diseases: GS-4774 is currently in Phase 2 clinical trials, designed to treat individuals chronically infected with the hepatitis B virus who are also on oral antiviral suppressive therapy. Additionally, GlobeImmune has various other infectious disease programs in the preclinical stage, such as GI-19000 for tuberculosis, GI-2010 for human immunodeficiency virus (HIV), and GI-18000 for hepatitis D virus infections. For oncology: GlobeImmune is advancing GI-6301, which targets cancers characterized by the expression of the brachyury protein. GI-6207 is progressing through Phase 2 clinical trials for medullary thyroid cancer. Furthermore, GI-4000 is a significant asset, undergoing Phase 2b clinical trials for resected pancreatic cancer, and is also in separate Phase 2 trials for non-small cell lung cancer and colorectal cancer. To support its endeavors, GlobeImmune maintains strategic alliances with industry leaders such as Gilead Sciences, Inc. and Celgene Corporation.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$575.00
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel GlobeImmune, Inc. (GBIM)

Kategorie

Healthcare
Preis GBIM mit Marktkapitalisierung von B
GlobeImmune, Inc. GlobeImmune, Inc.
GBIM
$0.0001
Marktkapitalisierung von GlobeImmune, Inc.(GBIM)
Marktkapitalisierung: $575.00
Mit Stand August 2026 hat GlobeImmune, Inc. eine Marktkapitalisierung von $575.00. Das macht GlobeImmune, Inc. laut unseren Daten zum 42634th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von GlobeImmune, Inc. von 2014 bis 2026
GBIM im Vergleich zu den Top 5 der beliebtesten stocks
Preis für GBIM Vermögenswert B Marktkapitalisierung von B Ergebnisse
GlobeImmune, Inc. GlobeImmune, Inc.
$939,206 $575.00
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.400T +939,206,132,943.48%
GlobeImmune, Inc. GlobeImmune, Inc.
$771,534 $575.00
Apple Inc. Apple Inc.
AAPL
$4.436T +771,533,962,683.83%
GlobeImmune, Inc. GlobeImmune, Inc.
$721,484 $575.00
Alphabet Inc. Alphabet Inc.
GOOG
$4.149T +721,484,466,091.48%
GlobeImmune, Inc. GlobeImmune, Inc.
$638,081 $575.00
Microsoft Corporation Microsoft Corporation
MSFT
$3.669T +638,080,739,900.00%
GlobeImmune, Inc. GlobeImmune, Inc.
$503,937 $575.00
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.898T +503,937,395,900.00%